GREP VC ZIPLINE SPV I LTD.

Marc Bathgate operates as a solo GP on this filing with no prior EDGAR history, signaling either a first institutional fund raise or a manager working primarily through direct relationships and secondaries rather than building a branded fund franchise, which limits LP visibility into decision-making patterns or operational depth across multiple vintages.

Filing in May 2026 aligns with renewed LP deployment after Q1 allocation cycles and positions the fund to deploy capital before mid-year performance reviews force budget lock; however, a $16M target at this stage suggests either a bolt-on acquisition, a rescue/continuation situation, or a manager testing institutional appetite before scaling.

Verify whether Bathgate retains key-man protection or if a co-investment option exists outside the SPV, as the 06b exemption and lack of prior filings mean standard governance provisions are not public — this directly affects liquidity timing and forced continuation rights if the GP is unavailable.